A matrix metalloproteinase inhibitor, batimastat, retards the development of osteolytic bone metastases by MDA-MB-231 human breast cancer cells in Balb C nu/nu mice (Q31876973)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A matrix metalloproteinase inhibitor, batimastat, retards the development of osteolytic bone metastases by MDA-MB-231 human breast cancer cells in Balb C nu/nu mice |
scientific article |
Statements
1 reference
A matrix metalloproteinase inhibitor, batimastat, retards the development of osteolytic bone metastases by MDA-MB-231 human breast cancer cells in Balb C nu/nu mice (English)
1 reference
Lee J
1 reference
Weber M
1 reference
Mejia S
1 reference
Bone E
1 reference
Watson P
1 reference
Orr W
1 reference
1 January 2001
1 reference
1 reference
106-113
1 reference
Identifiers
1 reference
1 reference